BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36794370)

  • 1. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
    van Lier YF; Vos J; Blom B; Hazenberg MD
    Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
    Gray AN; DeFilipp Z
    Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
    Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
    Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
    Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
    Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
    Staffas A; Burgos da Silva M; van den Brink MR
    Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of the intestinal microbiome to immune recovery after HCT.
    Wolfe AE; Markey KA
    Front Immunol; 2022; 13():988121. PubMed ID: 36059482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
    Köhler N; Zeiser R
    Front Immunol; 2018; 9():3179. PubMed ID: 30705680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
    DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.
    Schwabkey ZI; Jenq RR
    Annu Rev Med; 2020 Jan; 71():137-148. PubMed ID: 31986084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
    Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
    Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
    DeFilipp Z; Hohmann E; Jenq RR; Chen YB
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
    Andermann TM; Fouladi F; Tamburini FB; Sahaf B; Tkachenko E; Greene C; Buckley MT; Brooks EF; Hedlin H; Arai S; Mackall CL; Miklos D; Negrin RS; Fodor AA; Rezvani AR; Bhatt AS
    Transplant Cell Ther; 2021 Nov; 27(11):932.e1-932.e11. PubMed ID: 34274493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
    Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M
    Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
    Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
    Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    J Clin Oncol; 2023 Dec; 41(34):5306-5319. PubMed ID: 37235836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.